contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


circio-holding-asa-exercise-of-subscription-rights-in-the-rights-issue-by-primary-insiders-8

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Circio Holding is a pharmaceutical company. The company's specialist expertise is found in targeted immunotherapy used in the treatment of cancer patients. The company's operations consist of research and development and the medicines are sold under separate brands. Several partnerships in the market have been entered into to strengthen cooperation in the development of new immunotherapy. The company was founded in 2010 and is headquartered in Lysaker.

Circio Holding

Oslo, 28 January 2026: Reference is made to the stock exchange announcements by Circio Holding ASA (the “Company“) on 15 January 2026, regarding the commencement of the subscription period for...

<div class="mfn-body"><p><strong>Oslo, 28 January 2026: Reference is made to the stock exchange announcements by Circio Holding ASA (the “Company“) on 15 January 2026, regarding the commencement of the subscription period for the rights issue (the “Rights Issue“) and the receipt of subscription rights in the Rights Issue by certain primary insiders and close associates.</strong></p><p><strong>Certain primary insiders and close associates have on the dates as stated below, exercised subscription rights and subscribed for shares:</strong></p><ul><li>Victor Levitsky, Chief Scientific Officer of the Company has on 26 January 2026 exercised 32,698 subscription rights, thus entitling him to be allocated 32,698 offer shares in the Rights Issue. In addition, Victor Levitsky has subscribed for 217,302 offer shares without subscription rights, thereby subscribing for a total of 250,000 offer shares at the subscription price in the Rights Issue, i.e., NOK 1.00 per offer share, and to be allocated a corresponding number in warrants without additional consideration, subject to allocation by the board of directors and the completion of the Rights Issue.</li></ul><ul><li>Sølen AS, a closely associated company of Thomas Falck, Board member of the Company has on 27 January 2026 exercised 65,164 subscription rights, thus entitling the company to be allocated 65,164 offer shares in the Rights Issue. In addition, Sølen AS has subscribed for 134,836 offer shares without subscription rights, thereby subscribing for a total of 200,000 offer shares at the subscription price in the Rights Issue, i.e., NOK 1.00 per offer share, and to be allocated a corresponding number in warrants without additional consideration, subject to allocation by the board of directors and the completion of the Rights Issue.</li></ul><p>Please see the attached notifications of trade for information regarding the subscription rights exercised by primary insiders in the Rights Issue.</p><p>This information is subject to the disclosure requirements pursuant to article 19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.</p></div><div class="mfn-footer mfn-contacts mfn-a2287eff07eb"><p><strong class="mfn-heading-1">For further information, please contact:</strong><br>Erik Digman Wiklund, CEO<br>Phone: +47 413 33 536<br>Email: <a rel="noopener" href="mailto:erik.wiklund@circio.com">erik.wiklund@circio.com</a></p><p>Lubor Gaal, CFO<br>Phone: +34 683 34 3811<br>Email: <a rel="noopener" href="mailto:lubor.gaal@circio.com">lubor.gaal@circio.com</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/c1b91b9d-567d-4301-a53a-cca854a6462e/notification-trade-primary-insiders-exercised-rights.pdf" class="mfn-primary">Notification Trade Primary Insiders Exercised Rights</a></p></div>

Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders